巨子 ICON - 財經股票資訊及專家分析
快訊
資訊
    虛擬市場
    搜尋 股票/指數/編號

    快訊

    資訊

    Meridian Bioscience

    VIVO
    32.730
    0.150
    0.46%
    最少15分鐘延遲,股票資訊由第三方資訊供應商提供
    ・Meridian Bioscience - 延遲價格・最後更新於 10/08 9:30
    最高位
    32.810
    最低位
    32.440
    開市價
    --
    前收市價
    32.580
    成交量(千)
    9.05
    成交額(百萬)
    2.73
    買入
    --
    賣出
    --
    每手股數
    --
    市值(百萬)
    1,431.86
    市盈率
    33.400
    息率
    1.67%
    差價
    --
    52週高低
    34.375 - 17.200
    所有資料不保證絕對正確、完整、或實時,僅作為參考使用。投資涉及風險,過往業績並不代表將來表現,作任何投資決定或交易前,閣下應諮詢獨立專業意見。所有內容均不構成投資建議。

    企業資料

    公司名稱
    Meridian Bioscience
    證券代碼
    VIVO.US
    所屬板塊
    Diagnostics & Research
    公司業務
    Meridian Bioscience Inc is an integrated life science company. It develops and distributes diagnostic tests and reagents, as well as biologic substances used by pharmaceutical and biotechnology companies. Its Diagnostics segment manufactures tests primarily for gastrointestinal, viral, respiratory, & parasitic infectious diseases. Its testing platforms include isothermal DNA amplification, rapid immunoassays, and enzyme-linked immunoassays. The Life sciences segment sells b-antigens, antibodies, and reagents in bulk to other diagnostic manufacturers, the agriculture industry, and researchers. It also manufactures proteins that biopharmaceutical companies use in new drugs and vaccines. The entity has a business presence in the US and other countries.
    發行量
    43364448
    公司總部
    3471 River Hills Drive
    公司網址
    http://www.meridianbioscience.com
    公司電郵
    mbi@meridianbioscience.com
    公司電話
    +1 513 271-3700

    段永平回應牽頭OPPO及vivo造車傳聞:絕不會重出江湖

    孫素青·
    段永平回應牽頭OPPO及vivo造車傳聞:絕不會重出江湖

    關於

    Meridian Bioscience(VIVO.US)所屬的行業板塊為Diagnostics & Research。
    Meridian Bioscience Inc is an integrated life science company. It develops and distributes diagnostic tests and reagents, as well as biologic substances used by pharmaceutical and biotechnology companies. Its Diagnostics segment manufactures tests primarily for gastrointestinal, viral, respiratory, & parasitic infectious diseases. Its testing platforms include isothermal DNA amplification, rapid immunoassays, and enzyme-linked immunoassays. The Life sciences segment sells b-antigens, antibodies, and reagents in bulk to other diagnostic manufacturers, the agriculture industry, and researchers. It also manufactures proteins that biopharmaceutical companies use in new drugs and vaccines. The entity has a business presence in the US and other countries.
    截至10/08 09:30:00,Meridian Bioscience的股價升0.46,市值1,431.86百萬。Meridian Bioscience的市盈率及息率分別為33.400及1.67%。
    詳細公司背景可參考: http://www.meridianbioscience.com